A multi-institutional team including Yale School of Medicine (YSM) has demonstrated the ability to use ultrasound to stimulate specific neuro-metabolic pathways in the body to prevent or reverse the onset of Type 2 Diabetes in three different preclinical models.Ultrasound pulses were shown to modulate metabolic sensory nerve pathways in the liver. These nerve are designed to increase or decrease signalling to the brain during different metabolic events. Taken together these pulses were shown to prevent or reverse high blood sugar in multiple species and models of Type 2 Diabetes.The findings represent a significant milestone in the field of bio-electronic medicine, which is exploring new ways to treat chronic diseases such as diabetes using novel medical devices to modulate the body’s nervous system.
A multi-institutional team including Yale School of Medicine (YSM) has demonstrated the ability to use ultrasound to stimulate specific neuro-metabolic pathways in the body to prevent or reverse the onset of Type 2 Diabetes in three different preclinical models.Ultrasound pulses were shown to modulate metabolic sensory nerve pathways in the liver. These nerve are designed to increase or decrease signalling to the brain during different metabolic events. Taken together these pulses were shown to prevent or reverse high blood sugar in multiple species and models of Type 2 Diabetes.The findings represent a significant milestone in the field of bio-electronic medicine, which is exploring new ways to treat chronic diseases such as diabetes using novel medical devices to modulate the body’s nervous system.
